These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29414600)
21. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
22. Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss. Hsu YH; Chen WY; Chan CH; Wu CH; Sun ZJ; Chang MS J Exp Med; 2011 Aug; 208(9):1849-61. PubMed ID: 21844205 [TBL] [Abstract][Full Text] [Related]
23. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Fischer V; Haffner-Luntzer M Semin Cell Dev Biol; 2022 Mar; 123():14-21. PubMed ID: 34024716 [TBL] [Abstract][Full Text] [Related]
24. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells. Seo BK; Ryu HK; Park YC; Huh JE; Baek YH J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292 [TBL] [Abstract][Full Text] [Related]
25. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis. Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183 [TBL] [Abstract][Full Text] [Related]
26. Combined treatment with Dendrobium candidum and black tea extract promotes osteoprotective activity in ovariectomized estrogen deficient rats and osteoclast formation. Wang MY; Shen C; An MF; Xie CQ; Wu X; Zhu QQ; Sun B; Huang YP; Zhao YL; Wang XJ; Sheng J Life Sci; 2018 May; 200():31-41. PubMed ID: 29544757 [TBL] [Abstract][Full Text] [Related]
27. Coenzyme q10 regulates osteoclast and osteoblast differentiation. Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186 [TBL] [Abstract][Full Text] [Related]
28. Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. Kamiya S; Nakamura C; Fukawa T; Ono K; Ohwaki T; Yoshimoto T; Wada S J Bone Miner Metab; 2007; 25(5):277-85. PubMed ID: 17704992 [TBL] [Abstract][Full Text] [Related]
29. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation. Han SY; Lee KH; Kim YK Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250 [TBL] [Abstract][Full Text] [Related]
30. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
31. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans. Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336 [TBL] [Abstract][Full Text] [Related]
32. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094 [TBL] [Abstract][Full Text] [Related]
33. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553 [TBL] [Abstract][Full Text] [Related]
34. A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro. Murakami K; Kobayashi Y; Uehara S; Suzuki T; Koide M; Yamashita T; Nakamura M; Takahashi N; Kato H; Udagawa N; Nakamura Y PLoS One; 2017; 12(7):e0181126. PubMed ID: 28708884 [TBL] [Abstract][Full Text] [Related]
35. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451 [TBL] [Abstract][Full Text] [Related]
36. Estrogen Deficiency-Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice. Dou C; Ding N; Zhao C; Hou T; Kang F; Cao Z; Liu C; Bai Y; Dai Q; Ma Q; Luo F; Xu J; Dong S J Bone Miner Res; 2018 May; 33(5):899-908. PubMed ID: 29281118 [TBL] [Abstract][Full Text] [Related]
37. Regulatory effect of traditional Chinese medicinal formula Zuo-Gui-Wan on the Th17/Treg paradigm in mice with bone loss induced by estrogen deficiency. Lai N; Zhang Z; Wang B; Miao X; Guo Y; Yao C; Wang Z; Wang L; Ma R; Li X; Jiang G J Ethnopharmacol; 2015 May; 166():228-39. PubMed ID: 25824592 [TBL] [Abstract][Full Text] [Related]
38. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
39. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. Britton RA; Irwin R; Quach D; Schaefer L; Zhang J; Lee T; Parameswaran N; McCabe LR J Cell Physiol; 2014 Nov; 229(11):1822-30. PubMed ID: 24677054 [TBL] [Abstract][Full Text] [Related]